中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2013年
1期
6-7
,共2页
饶新辉%刘汉云%梁锦崧%陈刚%张自正
饒新輝%劉漢雲%樑錦崧%陳剛%張自正
요신휘%류한운%량금숭%진강%장자정
沐舒坦%肺癌%临床疗效
沐舒坦%肺癌%臨床療效
목서탄%폐암%림상료효
Ambroxol%Lung cancer%Clinical efficacy
目的:探讨大剂量沐舒坦对肺癌手术患者恢复的影响.方法:选取2010年3月-2012年3月在本院胸外科行手术治疗的138例肺癌患者为研究对象,应用随机数字表法将其分成对照组和观察组,每组各69例,对照组患者给予小剂量沐舒坦进行治疗,观察组给予大剂量沐舒坦进行治疗,两组患者其他治疗措施相同,比较对照组和观察组患者并发肺不张、肺部感染和急性呼吸衰竭的发生率.结果:观察组患者肺叶切除术后肺不张和肺部感染发生率明显低于对照组,差异有统计学意义(P<0.05),但是,两组急性呼吸衰竭差异无统计学意义(P>0.05),且对照组和观察组患者在不良反应发生率方面差异无统计学意义(P>0.05).结论:大剂量沐舒坦静脉滴注能够明显减少肺不张、肺部感染和急性呼吸衰竭发生率.
目的:探討大劑量沐舒坦對肺癌手術患者恢複的影響.方法:選取2010年3月-2012年3月在本院胸外科行手術治療的138例肺癌患者為研究對象,應用隨機數字錶法將其分成對照組和觀察組,每組各69例,對照組患者給予小劑量沐舒坦進行治療,觀察組給予大劑量沐舒坦進行治療,兩組患者其他治療措施相同,比較對照組和觀察組患者併髮肺不張、肺部感染和急性呼吸衰竭的髮生率.結果:觀察組患者肺葉切除術後肺不張和肺部感染髮生率明顯低于對照組,差異有統計學意義(P<0.05),但是,兩組急性呼吸衰竭差異無統計學意義(P>0.05),且對照組和觀察組患者在不良反應髮生率方麵差異無統計學意義(P>0.05).結論:大劑量沐舒坦靜脈滴註能夠明顯減少肺不張、肺部感染和急性呼吸衰竭髮生率.
목적:탐토대제량목서탄대폐암수술환자회복적영향.방법:선취2010년3월-2012년3월재본원흉외과행수술치료적138례폐암환자위연구대상,응용수궤수자표법장기분성대조조화관찰조,매조각69례,대조조환자급여소제량목서탄진행치료,관찰조급여대제량목서탄진행치료,량조환자기타치료조시상동,비교대조조화관찰조환자병발폐불장、폐부감염화급성호흡쇠갈적발생솔.결과:관찰조환자폐협절제술후폐불장화폐부감염발생솔명현저우대조조,차이유통계학의의(P<0.05),단시,량조급성호흡쇠갈차이무통계학의의(P>0.05),차대조조화관찰조환자재불량반응발생솔방면차이무통계학의의(P>0.05).결론:대제량목서탄정맥적주능구명현감소폐불장、폐부감염화급성호흡쇠갈발생솔.
Objective: To investigate the complications in patients with lung cancer after surgery by using larger dose of ambroxol.Method: The clinical data of one hundred and thirty-eight patients with lung cancer after surgery who were treated in our hospital from March 2010 to March 2012 were collected,then theY were divided into the control group(69 cases)and the observation group(69 cases)by using a random number table,patients in the control group was given small dose of ambroxol,but patients in the observation group was given larger dose of ambroxol,other measures of the two groups were the same,the pulmonary atelectasis,pulmonary infection and acute respiratory failure of two group was evaluated.Result: The incidence of the pulmonary atelectasis and pulmonary infection was lower in the observation group than that in the control group(P<0.05),and there were no statistical differences in the incidence of acute respiratory failure and adverse reaction(P>0.05).Conclusion: Continous intravenous pumping larger dose of ambroxol can into obtaine satisfactory curative effect,it can reduce the incidence of the pulmonary atelectasis,pulmonary infection and acute respiratory failure.